Melanoma resistance to photodynamic therapy: new insights.
Melanoma resistance to photodynamic therapy: new insights.
复制标题
DOI:
10.1515/hsz-2012-0228
复制
发表时间:
2013-02
影响因子:
3.7
通讯作者:
Hamblin MR
中科院分区:
文献类型:
--
作者:
Huang YY;Vecchio D;Avci P;Yin R;Garcia-Diaz M;Hamblin MR
Melanoma is the most dangerous form of skin cancer, with a steeply rising incidence and a poor prognosis in its advanced stages. Melanoma is highly resistant to traditional chemotherapy and radiotherapy, although modern targeted therapies such as BRAF inhibitors are showing some promise. Photodynamic therapy (PDT, the combination of photosensitizing dyes and visible light) has been tested for melanoma with some promising results, but melanoma is generally considered to also be resistant to PDT. Optical interference by the highly-pigmented melanin, the anti-oxidant effect of melanin, the sequestration of photosensitizers inside melanosomes, defects in apoptotic pathways, and the efflux of photosensitizers by ATP-binding cassette (ABC) transporters have all been implicated in melanoma resistance to PDT. Approaches to overcoming melanoma resistance to PDT include: the discovery of highly active photosensitizers absorbing in the 700–800-nm near infrared spectral region; interventions that can temporarily reduce the amount or the pigmentation of the melanin; compounds that can reverse apoptotic defects or inhibit drug-efflux of photosensitizers; and immunotherapy approaches that can take advantage of the ability of PDT to activate the host immune system to the treated tumor.
登录
查看更多内容
DOI:
10.3322/caac.20114
发表时间:
2011-07
期刊:
CA: a cancer journal for clinicians
影响因子:
--
作者:
Agostinis P;Berg K;Cengel KA;Foster TH;Girotti AW;Gollnick SO;Hahn SM;Hamblin MR;Juzeniene A;Kessel D;Korbelik M;Moan J;Mroz P;Nowis D;Piette J;Wilson BC;Golab J
通讯作者:
Golab J
影响因子:
1.1
作者:
AGUILAR, A;SCHOENDORFF, C;YUS, ES
通讯作者:
YUS, ES
影响因子:
3.3
作者:
BIOLO, R;JORI, G;RODGERS, MAJ
通讯作者:
RODGERS, MAJ
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
1.7
作者:
Glusac, Earl J.
通讯作者:
Glusac, Earl J.